secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2025-09-02T23:59:59+00:00
Accession:  0001641172-25-026110
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel removes ownership limit on Series A, B, C warrants, allowing full exercise of up to 654K shares
--------------------------------------------------------------------------------

- Amended warrants remove 4.99% Ownership Limitation on exercise and voting, effective September 1, 2025.
- Series A: 218K shares at $7.65; Series B: 218K at $9.00; Series C: 218K at $10.20, all expiring 5 years from issuance.
- Board and majority stockholder approved removal as disclosed in July 2025 Schedule 14C.
- No other terms of the warrants changed; cashless exercise provision remains in effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000164117225026110/0001641172-25-026110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000164117225026110/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-026110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer